Publication Date:
2023-12-21
Description:
With cardiometabolic diseases still topping the list of mortality causes and in facing the obesity and diabetes epidemic, there remains a great need to better understand the pathophysiological derangements underlying these conditions. During the past years, it has become increasingly appreciated that low grade systemic inflammation is a common hallmark of cardiometabolic disorders—not only concerning diabetes and atherosclerotic cardiovascular disease but also involving non-alcoholic fatty liver disease. Recently developed high-throughput laboratory techniques for lipidomics and metabolomics have enabled researchers to discern novel crosstalk pathways between lipid phenotypes and enhanced chronic inflammation. With this Special Issue of the Journal of Clinical Medicine, entitled “Novel Aspects of Lipoprotein Metabolism with a Focus on Systemic Inflammation”, researchers were invited to submit original papers and reviews on various topics, in particular, at the interface of lipid metabolism and inflammation.
Keywords:
R5-920
;
lipids
;
atherothrombosis
;
interleukin 1?
;
hepatic steatosis index
;
cholesterol
;
cytokines
;
small LDL
;
anti-apolipoprotein A-1 antibodies
;
lipoproteins
;
miR-33a
;
microparticles
;
microvesicles
;
platelets
;
chronic kidney disease
;
endothelial cells
;
sodium intake
;
lipid metabolism
;
HDL function
;
GlycA
;
acute coronary syndrome
;
passive diffusion
;
inflammation
;
metabolic disorder
;
type 2 diabetes mellitus
;
leukocytes
;
autoantibodies
;
cardiovascular disease
;
GRACE score
;
Breast cancer
;
triglycerides
;
prognosis
;
fatty liver index
;
gut microbiota
;
paraoxonase-1
;
canakinumab
;
carbamoylation
;
anti-apolipoprotein A-1 IgG
;
27-hydroxycholesterol
;
C-reactive protein
;
cholesterol homeostasis
;
lipoprotein subfractions
;
CANTOS
;
myocardial infarction
;
diabetic cardiomyopathy
;
Type 2 diabetes mellitus
;
retinol
;
anti-apolipoprotein A-I autoantibodies
;
non-alcoholic fatty liver
;
large VLDL
;
familial hypercholesterolemia
;
lipoprotein metabolism
;
free thiols
;
phospholipid transfer protein activity
;
obesity
;
foam cells
;
cardiovascular events
;
atherosclerotic cardiovascular disease (ASCVD)
;
biomarkers
;
cholesterol-lowering therapies
;
trimethylamine N-oxide related metabolites
;
adipose tissue
;
nuclear magnetic resonance spectroscopy
;
biomarker
;
metabolic syndrome
;
HOMA-IR
;
ANGPTL8
;
ANGPTL3
;
ANGPTL4
;
anti-apoA-1 IgG
;
adiponectin
;
retinol binding protein 4
;
HDL
;
TLR2/4
;
visceral adipose tissue (VAT)
;
LDL
;
renal transplant recipient
;
insulin resistance
;
infrared spectroscopy
;
C-statistics
;
large very low density lipoproteins
;
cholesterol efflux capacity
;
coronary artery calcium score
;
betaine
;
LDL cholesterol
;
bic Book Industry Communication::M Medicine
Language:
English
Format:
application/octet-stream
